Stay updated on GLPG2451 and GLPG2222 Combination in CF Clinical Trial

Sign up to get notified when there's something new on the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page version label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a minor page revision.
    Difference
    0.0%
    Check dated 2026-07-28T03:25:40.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, signaling a minor maintenance update. The study details and overall content remain unchanged.
    Difference
    0.0%
    Check dated 2026-07-06T16:07:48.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.0 to v3.6.2. This indicates a minor metadata update to the study record page rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-29T08:45:10.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Recruitment is now closed, and new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study) have been added to the study page, alongside a formatting update to the Intervention/Treatment heading and the page revision to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:23:09.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows revision: v3.5.5, replacing v3.5.4. This reflects an updated version of the study record's metadata.
    Difference
    0.0%
    Check dated 2026-06-08T04:39:11.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Lakefront Biotherapeutics NV is now listed as sponsor, replacing Galapagos NV. This indicates a shift in the organization responsible for the trial's conduct and governance.
    Difference
    0.2%
    Check dated 2026-05-24T19:33:36.000Z thumbnail image

Stay in the know with updates to GLPG2451 and GLPG2222 Combination in CF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page.